Indivior Pharmaceuticals Inc (INDV) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Indivior Pharmaceuticals Inc, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 21.36x | 820.38x | -16.47x | -68.72x | 12.26x | -7.28x |
| P/B Ratio | -45.77x | -4.71x | -11.12x | 58.97x | 12.38x | 13.14x |
| P/S Ratio | 3.62x | 1.38x | 1.94x | 3.36x | 3.18x | 1.67x |
| Profitability | ||||||
| Gross Margin | 80.1% | 80.6% | 84.1% | 83.2% | 83.9% | 85.0% |
| Operating Margin | 21.4% | 2.7% | -14.3% | -9.0% | 26.9% | -24.1% |
| Net Margin | 16.9% | 0.2% | -11.8% | -4.9% | 25.9% | -22.9% |
| EBITDA Margin | 24.5% | 7.1% | -9.1% | -5.1% | 30.1% | -19.0% |
| Liquidity | ||||||
| Current Ratio | 0.71x | 0.89x | 0.98x | 1.24x | 1.80x | 1.98x |
| Quick Ratio | 0.55x | 0.70x | 0.88x | 1.12x | 1.68x | 1.83x |
| Leverage | ||||||
| Debt/Equity | -3.58x | -1.08x | -1.48x | 5.40x | 1.41x | 3.48x |
YoY = year-over-year change. Source: FMP..